Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAX 855 in Surgery for Severe Hemophilia A
NCT01913405Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Started Dec 2013; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01913405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913405.